|
ARHGAP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.423100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.536400E-03 |
| Normal-vs-Stage2 |
9.964200E-02 |
| Normal-vs-Stage3 |
1.044810E-04 |
| Normal-vs-Stage4 |
1.31410000003829E-06 |
| Stage1-vs-Stage2 |
4.652800E-01 |
| Stage1-vs-Stage3 |
6.982500E-02 |
| Stage1-vs-Stage4 |
1.544040E-03 |
| Stage2-vs-Stage3 |
6.284400E-02 |
| Stage2-vs-Stage4 |
2.379400E-03 |
| Stage3-vs-Stage4 |
9.606400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.785200E-04 |
| Normal-vs-AfricanAmerican |
7.361600E-02 |
| Normal-vs-Asian |
7.637500E-04 |
| Caucasian-vs-AfricanAmerican |
7.249400E-01 |
| Caucasian-vs-Asian |
4.778800E-01 |
| AfricanAmerican-vs-Asian |
5.162600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.953900E-04 |
| Normal-vs-Female |
5.182000E-04 |
| Male-vs-Female |
7.566400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.615700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.574300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.232800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.415500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.591400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.822000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.007200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.864800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.337000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.402400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.503300E-03 |
| Classical-VS-Follicular |
8.058000E-01 |
| Classical-VS-Other |
8.529200E-01 |
| Classical-VS-Normal |
2.037200E-03 |
| Tall-VS-Follicular |
1.129580E-02 |
| Tall-VS-Other |
2.455200E-01 |
| Tall-VS-Normal |
2.18739999999773E-05 |
| Follicular-VS-Other |
7.949600E-01 |
| Follicular-VS-Normal |
1.584150E-02 |
| Other-VS-Normal |
1.810810E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.842900E-04 |
| Normal-vs-N1 |
2.384700E-04 |
| N0-vs-N1 |
1.877560E-01 |
|
|
